Pulmonary Hypertension Subtypes and Mortality in CKD

被引:43
|
作者
Edmonston, Daniel L. [1 ,2 ]
Parikh, Kishan S. [2 ,3 ]
Rajagopal, Sudarshan [3 ,4 ]
Shaw, Linda K. [2 ]
Abraham, Dennis [3 ]
Grabner, Alexander [1 ]
Sparks, Matthew A. [1 ,5 ]
Wolf, Myles [1 ,2 ]
机构
[1] Duke Univ, Sch Med, Dept Med, Div Nephrol, Durham, NC 27706 USA
[2] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA
[3] Duke Univ, Sch Med, Dept Med, Div Cardiol, Durham, NC 27706 USA
[4] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA
[5] Durham VA Med Ctr, Renal Sect, Durham, NC USA
基金
美国国家卫生研究院;
关键词
CHRONIC KIDNEY-DISEASE; ASYMMETRIC DIMETHYL ARGININE; HEART-FAILURE; ARTERIAL-HYPERTENSION; CARDIOVASCULAR EVENTS; POST-CAPILLARY; NITRIC-OXIDE; OUTCOMES; STAGE; PATHOPHYSIOLOGY;
D O I
10.1053/j.ajkd.2019.08.027
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Rationale & Objective: Pulmonary hypertension (PH) contributes to cardiovascular disease and mortality in patients with chronic kidney disease (CKD), but the pathophysiology is mostly unknown. This study sought to estimate the prevalence and consequences of PH subtypes in the setting of CKD. Study Design: Observational retrospective cohort study. Setting & Participants: We examined 12,618 patients with a right heart catheterization in the Duke Databank for Cardiovascular Disease from January 1, 2000, to December 31, 2014. Exposures: Baseline kidney function stratified by CKD glomerular filtration rate category and PH subtype. Outcomes: All-cause mortality. Analytical Approach: Multivariable Cox proportional hazards analysis. Results: In this cohort, 73.4% of patients with CKD had PH, compared with 56.9% of patients without CKD. Isolated postcapillary PH (39.0%) and combined pre- and postcapillary PH (38.3%) were the most common PH subtypes in CKD. Conversely, precapillary PH was the most com-mon subtype in the non-CKD cohort (35.9%). The relationships between mean pulmonary artery pressure, pulmonary capillary wedge pressure, and right atrial pressure with mortality were similar in both the CKD and non-CKD cohorts. Compared with those without PH, precapillary PH conferred the highest mortality risk among patients without CKD (HR, 2.27; 95% CI, 2.00-2.57). By contrast, in those with CKD, combined pre- and postcapillary PH was associated with the highest risk for mortality in CKD in adjusted analyses (compared with no PH, HRs of 1.89 [95% CI, 1.57-2.28], 1.87 [95% CI, 1.52-2.31], 2.13 [95% CI, 1.52-2.97], and 1.63 [95% CI, 1.12-2.36] for glomerular filtration rate categories G3a, G3b, G4, and G5/G5D). Limitations: The cohort referred for right heart catheterization may not be generalizable to the general popu lation. Serum creatinine data in the 6 months preceding catheterization may not reflect true baseline CKD. Observational design precludes assumptions of causality. Conclusions: In patients with CKD referred for right heart catheterization, PH is common and associated with poor survival. Combined pre- and postcapillary PH was common and portended the worst survival for patients with CKD
引用
收藏
页码:713 / 724
页数:12
相关论文
共 50 条
  • [1] Pulmonary Hypertension Subtypes and Mortality in Chronic Kidney Disease
    Edmonston, Daniel
    Parikh, Kishan S.
    Rajagopal, Sudarshan
    Shaw, Linda K.
    Abraham, Dennis
    Grabner, Alexander
    Sparks, Matthew A.
    Wolf, Myles
    CIRCULATION, 2019, 140
  • [2] Pulmonary Hypertension in CKD
    Bolignano, Davide
    Rastelli, Stefania
    Agarwal, Rajiv
    Fliser, Danilo
    Massy, Ziad
    Ortiz, Alberto
    Wiecek, Andrzej
    Martinez-Castelao, Alberto
    Covic, Adrian
    Goldsmith, David
    Suleymanlar, Gultekin
    Lindholm, Bengt
    Parati, Gianfranco
    Sicari, Rosa
    Gargani, Luna
    Mallamaci, Francesca
    London, Gerard
    Zoccali, Carmine
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 61 (04) : 612 - 622
  • [3] PULMONARY HYPERTENSION IN CKD PATIENTS
    Franczyk-Skora, Beata
    Gluba, Anna
    Kowalczyk, Mariusz
    Banach, Maciej
    Rysz, Jacek
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 455 - 455
  • [4] Classification of Pulmonary Hypertension in CKD
    Navaneethan, Sankar D.
    Yan, Jingyin
    Deswal, Anita
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (05) : 690 - 692
  • [5] Serum Biomarker Levels and Mortality Across Subtypes of Pulmonary Arterial Hypertension
    Hirsch, K.
    Nolley, S.
    Ralph, D. D.
    Leary, P. J.
    Rayner, S. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [6] Mortality, Kidney Failure, and Hospitalization Among Medicare Beneficiaries With CKD and Pulmonary Hypertension
    Navaneethan, Sankar D.
    Walther, Carl P.
    Gregg, L. Parker
    Bansal, Shweta
    Winkelmayer, Wolfgang C.
    Nambi, Vijay
    Niu, Jingbo
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 78 (05) : 700 - +
  • [7] Echocardiography to Screen for Pulmonary Hypertension in CKD
    Edmonston, Daniel L.
    Rajagopal, Sudarshan
    Wolf, Myles
    KIDNEY INTERNATIONAL REPORTS, 2020, 5 (12): : 2275 - 2283
  • [8] Pulmonary Hypertension In Systemic Sclerosis: Clinical Classification and Pulmonary Hypertension Subtypes
    Mohile, Monica
    Lucas, Mary
    Steen, Virginia D.
    Medsger, Thomas A., Jr.
    Domsic, Robyn T.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1100 - S1100
  • [9] Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKD
    Navaneethan, Sankar D.
    Roy, Jason
    Tao, Kelvin
    Brecklin, Carolyn S.
    Chen, Jing
    Deo, Rajat
    Flack, John M.
    Ojo, Akinlolu O.
    Plappert, Theodore J.
    Raj, Dominic S.
    Saydain, Ghulam
    Sondheimer, James H.
    Sood, Ruchi
    Steigerwalt, Susan P.
    Townsend, Raymond R.
    Dweik, Raed A.
    Rahman, Mahboob
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (03): : 877 - 886
  • [10] Diagnosis and Management of Pulmonary Hypertension in Patients With CKD
    Walther, Carl P.
    Nambi, Vijay
    Hanania, Nicola A.
    Navaneethan, Sankar D.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (06) : 935 - 945